Long-term safety and efficacy of tocilizumab (an anti-IL-6 receptor monoclonal antibody) in monotherapy, in patients with rheumatoid arthritis

被引：0
|
作者：
Nishimoto, N. [1 ]
Miyasaka, N. [2 ]
Yamamoto, K. [3 ]
Kawai, S. [4 ]
Takeuchi, T. [5 ]
Azuma, J. [6 ]
Kishimoto, T. [7 ]
机构：
[1] Osaka Univ, Grad Sch Frontier Biosci, Immune Lab Regulat, Suita, Osaka, Japan
[2] Tokyo Med & Dent Univ, Dept Med Rheumatol, Tokyo, Japan
[3] Univ Tokyo, Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan
[4] Toho Univ, Omori Med Ctr, Div Rheumatol, Tokyo, Japan
[5] Saitama Med Ctr, Saitama Med Sch, Dept Rheumatol & Clin Immunol, Kawagoe, Saitama, Japan
[6] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Clin Evaluat Med & Therapeut, Suita, Osaka 565, Japan
[7] Osaka Univ, Grad Sch Frontier Biosci, Lab Immune Regulat, Osaka, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [41] DNA microarray analysis of SLE related genes that respond to IL-6 blockade with tocilizumab, an anti-IL-6 receptor monoclonal antibody
    Ishikawa, S.
    Aoki, C.
    Yoshio, N.
    Nakahara, H.
    Saito, K.
    Tanaka, Y.
    Kishimoto, T.
    Nishimoto, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 474 - 474
  • [42] Efficacy and Safety of Anti-Interleukin 6 Receptor Monoclonal Antibody (Tocilizumab) in Colombian Patients With Takayasu Arteritis
    Alberto Canas, Carlos
    Canas, Felipe
    Hernan Izquierdo, Jorge
    Echeverri, Andres-Felipe
    Mejia, Mauricio
    Bonilla-Abadia, Fabio
    Tobon, Gabriel J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (03) : 125 - 129
  • [43] CLAZAKIZUMAB Humanized Anti-IL-6 Monoclonal Antibody Treatment of Rheumatoid Arthritis Treatment of Autoimmune Diseases Oncolytic
    Reviriego, C.
    DRUGS OF THE FUTURE, 2012, 37 (09) : 633 - 636
  • [44] LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF TOCILIZUMAB IN RITUXIMAB-REFRACTORY RHEUMATOID ARTHRITIS
    Farah, Z.
    Reddy, V.
    Ali, S.
    Price-Kuehne, F.
    Moore, S.
    Mackworth-Young, C.
    Ehrenstein, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 734 - 735
  • [45] Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
    Nishimoto, Norihiro
    Terao, Kimio
    Mima, Toru
    Nakahara, Hideko
    Takagi, Nobuhiro
    Kakehi, Takahiro
    BLOOD, 2008, 112 (10) : 3959 - 3964
  • [46] ANTI-IL-6 THERAPY MODULATES LEPTIN IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Lopez-Mejias, R.
    Genre, F.
    Remuzgo-Martinez, S.
    Mijares, V.
    Calvo-Alen, J.
    Blanco, R.
    Llorca, J.
    Castaneda, S.
    Gonzalez-Gay, M. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 945 - 946
  • [47] New insights and long-term safety of tocilizumab in rheumatoid arthritis
    Jones, Graeme
    Panova, Elena
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (10) : 195 - 199
  • [48] LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS CLINICAL TRIALS
    Taylor, A.
    Nash, P.
    Hall, S.
    Jones, G.
    Youssef, P.
    Porter-Brown, B.
    Thompson, L.
    Genovese, M.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 14 - 14
  • [49] LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS CLINICAL TRIALS
    Genovese, Mark C.
    Sebba, Anthony
    Rubbert-Roth, Andrea
    Scali, Juan
    Zilberstein, Moshe
    Thompson, Liz
    Van Vollenhoven, Ronald
    RHEUMATOLOGY, 2012, 51 : 75 - 76
  • [50] Anti-IL-6 Therapy Modulates Leptin in Patients with Rheumatoid Arthritis
    Remuzgo-Martinez, Sara
    Genre, Fernanda
    Pulito-Cueto, Veronica
    Mijares, Veronica
    Lera-Gomez, Leticia
    Calvo-Alen, Jaime
    Blanco, Ricardo
    Gualillo, Oreste
    Llorca, Javier
    Castaneda, Santos
    Lopez-Mejias, Raquel
    Angel Gonzalez-Gay, Miguel
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345